Filter
4694
Text search:
drug
policy
Featured
Recommendations
393
New Publications
1253
Language
Document type
No document type
2810
Studies & Reports
735
Guidelines
566
Manuals
208
Strategic & Response Plan
170
Fact sheets
67
Training Material
53
Situation Updates
47
Infographics
11
Resource Platforms
9
Brochures
5
Online Courses
5
App
2
Countries / Regions
India
220
Global
159
Kenya
156
Uganda
118
South Africa
118
Western and Central Europe
109
Nigeria
105
Ethiopia
105
Nepal
92
Liberia
80
Sierra Leone
79
Tanzania
79
Malawi
79
Zambia
77
Myanmar / Burma
73
Ghana
71
Africa
69
Latin America and the Carribbean
67
Bangladesh
63
Eastern Europe
60
Namibia
56
Ukraine
54
Rwanda
53
Asia
43
Zimbabwe
42
Philippines
36
South–East Asia Region
36
Cambodia
35
Lesotho
35
Russia
33
Indonesia
32
Botswana
28
Mozambique
22
Eswatini/ Swaziland
22
Congo, Democratic Republic of
21
Senegal
19
Syria
19
Burkina Faso
18
East and Southern Africa
16
Brazil
15
West and Central Africa
13
Haiti
12
Colombia
12
Middle East and North Africa
12
Venezuela
12
Cameroon
11
Pakistan
11
South Sudan
11
Thailand
11
Eastern Europe and Central Asia
11
Guinea
10
Albania
10
Tajikistan
10
Georgia
10
Germany
9
Sudan
9
Vietnam
9
China
8
Afghanistan
7
Laos
7
Moldova
7
USA
6
Benin
6
North Macedonia
6
Sri Lanka
6
Yemen
6
Paraguay
6
Armenia
6
Peru
5
El Salvador
5
Mexico
5
Western Pacific Region
5
North America
5
Somalia
4
Iraq
4
Jordan
4
Central African Republic
4
Argentina
4
Libya
4
Timor Leste/ East Timor
4
Iran
4
United Kingdom
4
Lebanon
3
Turkey
3
Fiji
3
Bhutan
3
Palestine
3
Estonia
3
Kyrgyzstan
3
Jamaica
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Serbia
2
Hungary
2
Bolivia
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Romania
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Egypt
1
Gambia
1
Ireland
1
Dominican Republic
1
Switzerland
1
Honduras
1
Greece
1
Angola
1
Guatemala
1
Madagascar
1
Nicaragua
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1875
Clinical Guidelines
360
Public Health
228
Women & Child Health
169
Key Resources
138
Capacity Building
55
Pharmacy & Technologies
51
Toolboxes
HIV
644
TB
515
Mental Health
418
AMR
248
COVID-19
167
Pharmacy
137
NTDs
122
NCDs
90
Malaria
86
Caregiver
82
Planetary Health
66
Ebola & Marburg
57
Global Health Education
56
Disability
53
Refugee
51
Conflict
46
Rapid Response
45
Health Financing Toolbox
43
Polio
24
2.0 Rapid Response
23
Natural Hazards
15
Specific Hazards
13
Cholera
10
Social Ethics
10
Zika
7
In this report, potential reasons for this apparent
contradiction between cherished human values
and observed social actions are explored with a
view to better formulating concrete steps that
governments and other stakeholders can take to
reshape social attitudes and public
...
In September, 2018, the first international Medicine Quality and Public Health Conference was held at Oxford University, UK, to discuss opportunities and solutions to ensure that all people have access to affordable and quality-assured medical products. Delegates developed the short Oxford Statement
...
The National Strategy for Natural Disaster, Prevention, Response and Mitigation to 2020, which outlines Vietnam’s main disaster risk management objectives and the National Target Program (NTP) form the overarching policy framework for disaster ris
...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f
...
interim Guidance 1 December 2020. Updated version
This document provides updated guidance on mask use in health care and community settings, and during home care for COVID-19 cases. It is intended for policy makers, public health and infection prev
...
Practical actions in cities to strengthen preparedness for the COVID-19 pandemic and beyond
recommended
This document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in cities and urban settings”. It provides local authorities, leaders and policy-makers in cities with a checklist tool to ensure that key areas have been
...
Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups
recommended
Treating children infected with intestinal worms is one of the simplest and most cost–effective ways to improve their health.
The recommendations are intended for a wide audience, including policy-makers and their expert advisers as well as tech
...
BMJ Global Health2020;5:e002914. doi:10.1136/bmjgh-2020-002914
The evidence produced in mathematical models plays a key role in shaping policy decisions in pandemics. A key question is therefore how well pandemic models relate to their implementa
...
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog
...
The primary aim of this assessment is to evaluate current approaches to malaria surveillance in Myanmar and to provide a set of practical and feasible recommendations to further strengthen the surveillance system in the short to medium term. The assessment focuses on the surveillance of malaria case
...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the
...
Infectious disease outbreaks are frequently characterized by scientific uncertainty, social and institutional disruption, and an overall climate of fear and distrust. Policy makers and public health professionals may be forced to weigh and prioritiz
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug
...
The Global Programme on Tuberculosis & Lung Health of the World Health Organization (WHO/GTB) is now combining all current recommendations into one overall set of consolidated guidelines on TB. The guidelines contain recommendations pertaining to all areas related to the programmatic management of T
...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evide
...
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and p
...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S
...
In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These guidelines outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have s
...
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and morbidity in urban poor settings today requires an expansion of effective Maternal and Newborn Health (MNH) care services and lowering the barrier
...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G
...
